US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Company Reports: research reports

Research your competitors and discover new corporate prospects in the biotechnology industry with company reports and profiles.
RSS Feeds

Biotechnology Company Reports market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Physician Views: How do oncologists expect use of Kyprolis will be affected by Amgen's positive ASPIRE data?
8/14/2014 | published by: FirstWord
... myeloma patients, thus greatly multiplying the drug's commercial potential. In the three quarters since the deal closed, investors have put up with relatively unremarkable sales growth for Kyprolis but have been getting antsy waiting for ...  |  read more...
USD 645
Vivia Biotech, S.L. - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... Vivia provides treatments for hematological cancers, such as leukemia, lymphoma and multiple myeloma. The company concentrates on personalized medicine test for hematologic cancers. Its technology platform consists of cytometry instruments. The company also has extended ...  |  read more...
USD 750
Toscana Biomarkers Srl - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... probes for biomarkers identification. The company‚Äôs diagnostic tests include ELISA, multiplex assays on beads or chip, and point of care assays. It offers autoantibody blood tests, blood tests to measure inflammation and organ function, clinical ...  |  read more...
USD 750
Proplex Technologies, Llc - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... the effectiveness of cancer treatment. Proplex Technologies's 2D HPLE technology is a two-dimensional polyacrylamide gel electrophoresis used in applications to identify critical biomarkers in several human diseases. The company's technology is also used in identifying ...  |  read more...
USD 750
Metabolon, Inc. - Product Pipeline Analysis, 2014 Update
8/13/2014 | published by: GlobalData
... Metabolon's Quantose IR test is a blood test performed for detecting early-stage insulin resistance; and Prostarix and Prostarix Plus tests are urine-based tests used in the detection of prostate cancer risk. The company partners with ...  |  read more...
USD 750
Biotechnology in the United Kingdom
8/12/2014 | published by: Plimsoll Publishing Ltd.
... activities such as dna, contract pharmaceutical drug development services, biotechnology, microbiology, hygiene and includes a wealth of information on the financial trends over the past four years. latest Biotechnology analysis is perfect for investors to: ...  |  read more...
USD 525
Enzo Biochem, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Cleveland Biolabs, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cleveland Biolabs, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Compugen, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Compugen, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
WaferGen Bio:systems, Inc : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Cell Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cell Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer CropScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer MaterialScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer MaterialScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Galapagos NV : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Generex Biotechnology Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Generex Biotechnology Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
InterMune, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' InterMune, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Intercell AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Intercell AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Marina Biotech, Inc. (formerly MDRNA, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Marina Biotech, Inc. (formerly MDRNA, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Verenium Corporation (Formerly Diversa Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Verenium Corporation (Formerly Diversa Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Cytori Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cytori Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Asuragen, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Asuragen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
PolyTherics Limited : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' PolyTherics Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Life Technologies Corporation (formerly Invitrogen Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Life Technologies Corporation (formerly Invitrogen Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10